Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Celsion Corp. | -3.810% | 0.000% | -17.969% | -14.634% | 76.471% | -93.333% | -95.502% |
India Globalization Capital | -1.150% | -3.333% | -36.727% | 43.802% | 32.824% | -73.374% | -63.994% |
BioInvent International AB | -6.160% | 6.219% | 29.541% | 93.847% | 97.866% | -38.946% | 13.462% |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat